The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors

Current Treatment Options in Oncology - United States
doi 10.1007/s11864-015-0356-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment Outcomes and Late Toxicities in Patients With Embryonal Central Nervous System Tumors

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Serum VEGF-A Concentrations in Patients With Central Nervous System (CNS) Tumors

PLoS ONE
Multidisciplinary
2018English

Tumors of the Pediatric Central Nervous System

Journal of Neuro-Ophthalmology
MedicineOphthalmologyNeurology
2013English

Immunopathology of Central Nervous System Tumors

Immunome Research
2014English

Rare Primary Central Nervous System Tumors

Rare Tumors
OncologyHistology
2014English

Modulation of the Endocannabinoid System Following Central Nervous System Injury

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

A Phase I Trial of Lenalidomide in Patients With Recurrent Primary Central Nervous System Tumors

Clinical Cancer Research
Cancer ResearchOncology
2007English

Modulation of Gene Expression in Human Central Nervous System Tumors Under Methionine Deprivation-Induced Stress

Cancer Research
Cancer ResearchOncology
2004English

Biomarkers in Tumors of the Central Nervous System - A Review

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy